Cochlear Ltd slashed FY26 underlying net profit forecast to A$290‑A$330 million from A$435‑A$460 million.
Shares plunged 38.2% to A$103.87, hitting a ten‑year low—the lowest level since April 2016.
Company cites weaker demand, US consumer sentiment, hospital capacity limits and Middle East geopolitical risk, flagging a possible A$10 million receivables provision.
Stronger Australian dollar may cut earnings by about A$25 million after tax and lower production volumes will pressure margins.